Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials

Author
De Vita, Ferdinando
Chao, Joseph
Fuchs, Charles S.
Shitara, Kohei
Tabernero, Josep
Muro, Kei
Van Cutsem, Eric
Bang, Yung-Jue
Landers, Gregory
Yen, Chia-Jui
Chau, Ian
Elme, Anneli
Lee, Jeeyun
Ozguroglu, Mustafa
Catenacci, Daniel
Yoon, Harry H.
Chen, Erluo
Adelberg, David
Shih, Chie-Schin
Shah, Sukrut
Bhagia, Pooja
Wainberg, Zev A.
Metadata
Show full item record
Abstract
IMPORTANCE Immunotherapy has been associated with improved outcomes among patients who have received previous treatment for microsatellite instability-high (MSI-H) tumors.
URI
http://hdl.handle.net/20.500.12627/172322
https://doi.org/10.1001/jamaoncol.2021.0275
Collections